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abusive misuse, and psychotomimetic side effects.4 In the
cases described herein, we suggest that rapid infusion
of S-(+)-ketamine may offer less tolerability compared
to the racemic formulation. However, the infusion rate
used to treat these patients may explain, at least in part,
the poor tolerability observed. Therefore, we maintain that
ketamine administration should only be performed in the
inpatient setting, with supporting services and monitoring
available,5 using a slow infusion over at least 40 minutes.
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Numerous studies report higher HIV infection rates among
psychiatric patients than in the general population.1 Rela-
tive to other HIV-affected populations, they have higher
rates of HIV-related risk behaviors in fewer sexual occa-
sions, including multiple partners, partners of unknown or
positive HIV status, sex in exchange for money, shelter
or goods, and low condom use rates.2 We present a new
HIV risk index (RI)3 that takes into account differential risk
associated with these factors.
Anal/vaginal receptive sex is riskier than insertive prac-
tices. Sex acts with partners of unknown/positive HIV status
are riskier than those with HIV-negative partners, regardless
of partner type.4 Lastly, sex acts with steady, casual, and
exchange partners are associated with different HIV risk.5
Our RI assigns differential risk to each sex act and
sums risk across sex acts. The differential risk consists
of three risk coefficients: 1) partner (type and HIV status);
2) vaginal sex (insertive or receptive) per sex occasion;
and 3) anal sex (insertive or receptive) per sex occasion.
Risk coefficients for vaginal/anal directionality are based
on CDC transmission risk values,6 while coefficients pro-
posed for partner type were determined on the basis of
expert opinion and face validity (Table 1).
RI is estimated for each sex partner (RIn); the sum of all
RIn corresponds to the total RI score. We provide three
examples to demonstrate the new RI in comparison to
focusing only on condomless sex proportions.
Example 1. A man had four anal sex acts, one insertive
and three receptive, all condomless, with a casual male
HIV-unknown partner. Taking into account the three risk
coefficients, this person would have an RI = 0.90*(0.11*1+
1.38*3) = 3.83. Based solely on the proportion of condomless
sex occasions, this person’s risk would be classified as 100%.
Example 2. A man had three vaginally insertive acts, all
condomless, with a casual HIV-negative partner. This
person would have an RI = 0.10*(0.04*3) = 0.01. His risk
Table 1 Risk coefficients by sex partner type and HIV status,
sex occasions
Sex partner RC

















RI formula: RIn (Partner N) = RC [Partner type and HIV status]
*(RC[vaginal sex] *number of condomless vaginal acts + RC[anal
sex] *number of condomless anal acts)
MSM = men who have sex with men; RC = risk coefficient; RI = risk
index.
*Steady partner: someone participants think of as a steady or main
partner (spouse, girlfriend/boyfriend, lover, fiancée); casual partner:
someone participants had sex with for love or fun, but did not think
of as a main or steady partner; exchange partner: someone
participants had sex with in exchange for something (money, drugs,
alcohol, cigarettes, a place to sleep), whether the transaction was
clearly negotiated or implied.
wSex occasions risk coefficients are based on epidemiological data
provided by CDC.6
Rev Bras Psiquiatr. 2017;39(2)
Letters to the Editors 189
classification based on the proportion of condomless
sex occasions is 100%, which would not distinguish him
meaningfully from the man in Example 1.
Example 3. A woman had sex with two male partners,
steady HIV-negative and exchange HIV-unknown. The one
sex occasion with the steady partner was condomless;
with the exchange partner, she had seven sex occasions,
of which one was condomless vaginal and three were
condomless anal (total sex occasions = 8; condomless sex
occasions = 5). Thus, RI1 (Partner 1) = 0.01*(0.08*1) = 0.001;
RI2 (Partner 2) = 0.90*(0.01*1+1.38*3) = 3.74; RITotal =
0.001+3.74 = 3.74. The proportion of condomless sex
occasions would be 62.5%. Relative to Example 1, the RI
shows this person’s risk approximating his, though the
proportion of condomless occasions shows her to be at
considerably less risk.
Using our RI, possible misclassifications of risk based
solely on the proportion of condomless sex occasions were
identified. RI offers greater precision in estimating risk
within psychiatric and potentially other populations now
that Brazil is considering pre-exposure prophylaxis (PrEP –
PrEPBrasil.com.br) for those at high risk. Additional
behavioral and infection rate data are needed to further
differentiate and validate high risk.
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Schizophrenia is a chronic disorder with high potential to
incapacitate patients for social life and participation in the
workforce. The continuous use of antipsychotics has enabled
a reduction in length of hospital stay and in number of
relapses, allowing patients to remain in the community for
longer. As a consequence, economic costs and burden
are reduced. The choice of antipsychotic agent potentially
affects clinical outcomes.1
In the context of the public health system of the state of
Minas Gerais, Brazil, hospital treatment of schizophrenia
is currently directed to the management of relapses, usually
consisting of short-term hospitalizations followed by referral
to outpatient care.2 Since research on current pharmaco-
therapy of schizophrenia in Brazil is scarce, our study aims
to describe prescription patterns for schizophrenia in the
setting of public hospital care.
The study sample comprised 1,928 patients admitted
for schizophrenia to three public psychiatric hospitals in
Minas Gerais (Instituto Raul Soares, Hospital Galba Velloso,
and Centro Hospitalar Psiquiátrico de Barbacena) between
2010-2014. In these hospitals, both typical and atypical
antipsychotic agents were routinely available for inpatients.
However, the prescription of atypicals required additional
paperwork and their continuation after discharge was pos-
sible, but not advocated.3 To analyze psychopharmaceutical
prescribing practices in this sample, we conducted a
detailed analysis of patients’ prescriptions on the day
before their discharge from hospital.
Typical antipsychotics (haloperidol, chlorpromazine, thio-
ridazine, levomepromazine, trifluoperazine) were the most
frequently prescribed drugs; among the atypicals, risper-
idone was preferred. Similar results were found by Machado
et al.4 in their study, conducted in the emergency depart-
ment of a Brazilian public general hospital in the state of
Paraná. (We were unable to find other reports of a similar
nature in the literature.) Atypical antipsychotics are con-
sidered first-line choices by some,5,6 but not all,7 clinical
guidelines, and there is a sustained debate on their eco-
nomic advantages in developing countries.8 Although cloza-
pine has proven useful in reducing readmission risks in
schizophrenia,9 it was used in only 4.2% of admissions in
our sample, a prevalence lower than that reported inter-
nationally (8-25%).10,11
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